新型INHAT抑制因子通过促进胶质瘤干细胞核糖体DNA转录驱动胶质母细胞瘤生长
研究探讨新型INHAT抑制因子(NIR)在胶质瘤干细胞(GSC)核糖体生物发生中的作用。NIR在GSC核仁富集,其高表达预测胶质母细胞瘤(GBM)患者生存不良;敲低NIR通过抑制rDNA转录和前核糖体RNA合成抑制GSC增殖与肿瘤生长,机制上与核仁素(NCL)和核磷蛋白1(NPM1)协同。
要点
- NIR高表达预测GBM患者生存不良,且在GSC核仁中富集。
- 敲低NIR抑制rDNA转录和前核糖体RNA合成,抑制GSC增殖与肿瘤生长。
- NIR与NCL和NPM1协同激活rDNA转录以促进GSC增殖。
核心结论
- NIR介导的rDNA转录在GBM恶性进展中起关键作用,靶向该轴可能为GBM提供新的治疗策略。
研究设计与样本
- 采用免疫印迹、免疫组化和免疫荧光分析检测NIR在GSC和人GBM中的表达。
- 使用shRNA介导的敲低评估NIR在GSC和GSC来源的原位GBM异种移植瘤中的作用和功能意义。
- 进行质谱分析、染色质免疫沉淀和其他生化 assay 以明确NIR促进GBM进展的分子机制。
主要发现
- NIR高表达预测GBM患者生存不良。
- NIR富集于人GBM中GSC的核仁。
- 破坏NIR通过抑制rDNA转录和前核糖体RNA合成显著抑制GSC增殖和肿瘤生长。
- NIR通过与核仁素(NCL)和核磷蛋白1(NPM1)协同激活rDNA转录以促进GSC增殖。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cancer cells including cancer stem cells exhibit a higher rate of ribosome biogenesis than normal cells to support rapid cell proliferation in tumors. However, the molecular mechanisms governing the preferential ribosome biogenesis in glioma stem cells (GSCs) remain unclear. In this work, we show that the novel INHAT repressor (NIR) promotes ribosomal DNA (rDNA) transcription to support GSC proliferation and glioblastoma (GBM) growth, suggesting that NIR is a potential therapeutic target for GBM. METHODS: Immunoblotting, immunohistochemical and immunofluorescent analysis were used to determine NIR expression in GSCs and human GBMs. Using shRNA-mediated knockdown, we assessed the role and functional significance of NIR in GSCs and GSC-derived orthotopic GBM xenografts. We further performed mass spectrometry analysis, chromatin immunoprecipitation, and other biochemical assays to define the molecular mechanisms by which NIR promotes GBM progression. RESULTS: Our results show that high expression of NIR predicts poor survival in GBM patients. NIR is enriched in the nucleoli of GSCs in human GBMs. Disrupting NIR markedly suppresses GSC proliferation and tumor growth by inhibiting rDNA transcription and pre-ribosomal RNA synthesis. In mechanistic studies, we find that NIR activates rDNA transcription to promote GSC proliferation by cooperating with Nucleolin (NCL) and Nucleophosmin 1 (NPM1), 2 important nucleolar transcription factors. CONCLUSIONS: Our study uncovers a critical role of NIR-mediated rDNA transcription in the malignant progression of GBM, indicating that targeting this axis may provide a novel therapeutic strategy for GBM.
引用
- Tao W, Lei H, Luo W, et al. Novel INHAT repressor drives glioblastoma growth by promoting ribosomal DNA transcription in glioma stem cells. Neuro Oncol. 2023. PMID: 36521011. doi:10.1093/neuonc/noac272
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。